Abstract:Background Individuals with Parkinson's Disease (PD) commonly have reduced exercise capacity, which impacts autonomy and quality of life. The 6-minute walk test (6MWT) has adequate measurement properties to assess exercise capacity in this population. However, these individuals have a reduced fatigue threshold, which may make it difficult to apply prolonged exercise tests. Two-minute walk test (2MWT) is a potential alternative to optimize the measurement of this outcome. Objectives To assess the t validity of the 2MWT for assessing exercise capacity in individuals with PD. Methods A methodological study was developed. People with idiopathic PD, age ≥ 50 years, medically stable for at least 6 months, classified between the stages 1-3 of the modified Hoehn and Yahr scale were included. Individuals were instructed to walk the longest possible distance in six minutes in a 30-meter corridor. Standardized stimuli were provided every minute of the test. In the second and sixth minutes, the distances covered were recorded. Two tests were performed with an interval of 30 minutes or until hemodynamic stabilization. The best total distance covered (in meters) was used in the analyses. Descriptive statistics was used to characterize the sample. Pearson's Correlation Coefficient was used to investigate the correlation between the tests (6MWT and 2MWT). Regression analysis was used to develop an equation to predict the distance covered in the 6MWT based on the 2MWT. The intraclass correlation coefficient (ICC) was used to assess the validity of the equation. The magnitude of the correlation was classified as follows: very low≤ 0.25; low=0.26-0.49; moderate=0.50-0.69; high = 0.70-0.89; and very high = 0.90-1.00. The significance level was α=0.05. Results Forty-six individuals, 32 males (69.6%), mean age 66.93±8.34 years, and mean disease duration 8.5±5.96 years were included. Most were classified at stage 2.0 (54 .3%) and 3.0 (17.4%) on the modified Hoehn & Yahr Scale. Significant, and very high magnitude correlation between the distance covered in the tests was found (6MWT and 2MWT) (r=0.95; p < 0.001). The equation developed to estimate the distance covered in the 6MWT explained 91% of the 6MWT variability: 6MWTdistance=46,31+(2,40x2MWTdistance). Significant, and very high magnitude agreement between the distance covered in the 6MWT and predicted by the equation was found (ICC= 0.90; p < 0.001). Conclusion Preliminary results indicate adequate validity of the 2MWT to assess exercise capacity in individuals with PD. Furthermore, the developed equation was adequate to predict the distance covered in the 6MWT based upon in the distance covered in the 2MWT. However, the study must be completed to ensure the results. Implications The 2MWT has potential to assess exercise capacity in individuals with PD, and the developed equation can estimate the distance covered in the 6MWT. This can optimize the measurement of this result, making the measurement feasible.

The minimally clinically important difference in the 2-minute walk test for people in the subacute phase after a stroke

Estimation of minimal clinically important difference for 6-minute walking distance in patients with acute stroke using anchor-based methods and credibility instruments

Pooled Minimal Clinically Important Differences of the Mini-Balance Evaluation Systems Test in Patients with Early Subacute Stroke: A Multicenter Prospective Observational Study

The minimal clinically important difference in Berg Balance Scale scores among patients with early subacute stroke: a multicenter, retrospective, observational study

Test-retest Reliability and Minimum Detectable Change of 2-Minute Walk Test among Individuals with Knee Osteoarthritis

Minimal Clinically Important Differences in Treadmill, 6-Minute Walk, and Patient-Based Outcomes Following Supervised and Home-Based Exercise in Peripheral Artery Disease.

VALIDITY OF THE 2-MINUTE WALK TEST TO ASSESS EXERCISE CAPACITY IN INDIVIDUALS WITH PARKINSON DISEASE

Establishing minimal clinically important differences and cut-off values for the lower limb motricity index and trunk control test in older patients with acute stroke: a prospective cohort study

The validity and reliability of the Incremental Shuttle Walk Test and Six-minute Walk Test compared to an Incremental Cycle Test for people who have had a mild-to-moderate stroke

Application of Six-minute Walk Test in Acute Stroke Patients

Minimal important difference of Berg Balance Scale, performance-oriented mobility assessment and dynamic gait index in chronic stroke survivors

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

The minimal clinically important difference of two multifaceted fatigue evaluation questionnaires in chronic stroke

The minimal important difference for the Postural Assessment Scale for Stroke Patients in the subacute stage

Characterization of Walking in Mild Parkinson's Disease: Reliability, Validity and Discriminant Ability of the Six-Minute Walk Test Instrumented with a Single Inertial Sensor

Minimal clinically important differenceof fatigue severity scale in patients with chronic stroke

Exploring Alternative Measurements of Cardiorespiratory Fitness in Patients With Mild Ischemic Stroke at Acute Phase

Between-Day Reliability of the Gait Characteristics and Their Changes During the 6-Minute Walking Test in People With Multiple Sclerosis

Minimal Clinically Important Difference of Scales Reported in Stroke Trials: A Review

Estimating the minimum clinically important difference (MCID) of the five-repetition sit-to-stand test in patients with lumbar disc herniation

Minimal detectable change of gait and balance measures in older neurological patients: estimating the standard error of the measurement from before-after rehabilitation data thanks to the linear mixed-effects models